Global Custom Market Research Reports Provider Company

phone

Oncogenex Pharmaceuticals, Inc. (OGXI) - Financial and Strategic SWOT Analysis Review

  • Published Date: 01 Feb 2015
  • Number of Pages: 25
  • Category: Healthcare and Medical
  • Country: United States of America

Summary

Oncogenex Pharmaceuticals, Inc. (OncoGenex) is a biopharmaceutical company. The company develops and commercializes therapies for cancer. Its products include custirsen, apatorsen and OGX-225. Oncogenex’s apatorsen inhibits production of heat shock protein 27, which is an intracellular protein that is prominent in various types of cancer. The company’s OGX-225 is in pre-clinical development. Its OGX-225 is a second generation antisense drug candidate that inhibits the production of insulin growth factor binding proteins -2 and -5 IGFBP-2 and IGFBP-5. The company partners with University of British Columbia and cancer researchers. OncoGenex is headquartered in Bothell, Washington, the US.

Oncogenex Pharmaceuticals, Inc. Key Recent Developments

Nov 05, 2013: OncoGenex to Present at Credit Suisse Healthcare Investor Conference
Oct 30, 2013: OncoGenex to Report Financial Results for Third Quarter 2013 and Address Key Questions from Investors on November 7, 2013
Aug 08, 2013: OncoGenex Pharmaceuticals Provides Clinical Development Program Overview and Reports Financial Results for Second Quarter 2013
Aug 07, 2013: OncoGenex Pharmaceuticals to Present at Upcoming Investor Conference
Aug 07, 2013: OncoGenex Pharmaceuticals to Present at Upcoming Investor Conference

This comprehensive SWOT profile of Oncogenex Pharmaceuticals, Inc. provides you an in-depth strategic analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.

This company report forms part of GlobalData’s ‘Profile on Demand’ service, covering over 50,000 of the world’s leading companies. Once purchased, GlobalData’s highly qualified team of company analysts will comprehensively research and author a full financial and strategic analysis of Oncogenex Pharmaceuticals, Inc. including: and deliver this direct to you in pdf format within two business days. (excluding weekends).

The profile contains critical company information including:

- Business description – A detailed description of the company’s operations and business divisions.
- Corporate strategy – Analyst’s summarization of the company’s business strategy.
- SWOT Analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
- Company history – Progression of key events associated with the company.
- Major products and services – A list of major products, services and brands of the company.
- Key competitors – A list of key competitors to the company.
- Key employees – A list of the key executives of the company.
- Executive biographies – A brief Summary of the executives’ employment history.
- Key operational heads – A list of personnel heading key departments/functions.
- Important locations and subsidiaries – A list and contact details of key locations and subsidiaries of the company.
- Key manufacturing facilities – A list of key manufacturing facilities of the company.
- Detailed financial ratios for the past five years – The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
- Interim ratios for the last five interim periods – The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.

Note*: Some sections may be missing if data is unavailable for the company.

Key benefits of buying this profile include:

You get detailed information about the company and its operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.

Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.
- The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.

Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.
- Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.

Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.
- Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.

Gain key insights into the company for academic or business research.
- Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.

Publisher Name : GlobalData

Section 1 - About the Company

Oncogenex Pharmaceuticals, Inc. - Key Information
Oncogenex Pharmaceuticals, Inc. - Overview
Oncogenex Pharmaceuticals, Inc. - Key Employees
Oncogenex Pharmaceuticals, Inc. - Key Employee Biographies
Oncogenex Pharmaceuticals, Inc. - Key Operational Heads
Oncogenex Pharmaceuticals, Inc. - Major Products and Services
Oncogenex Pharmaceuticals, Inc. - History
Oncogenex Pharmaceuticals, Inc. - Company Statement
Oncogenex Pharmaceuticals, Inc. - Locations And Subsidiaries
Oncogenex Pharmaceuticals, Inc. - Key Manufacturing facilities
Head Office
Other Locations & Subsidiaries

Section 2 - Company Analysis

Oncogenex Pharmaceuticals, Inc. - Business Description
Oncogenex Pharmaceuticals, Inc. - Corporate Strategy
Oncogenex Pharmaceuticals, Inc. - SWOT Analysis
SWOT Analysis - Overview
Oncogenex Pharmaceuticals, Inc. - Strengths
Oncogenex Pharmaceuticals, Inc. - Weaknesses
Oncogenex Pharmaceuticals, Inc. - Opportunities
Oncogenex Pharmaceuticals, Inc. - Threats
Oncogenex Pharmaceuticals, Inc. - Key Competitors

Section 3 - Company Financial Performance Charts

Oncogenex Pharmaceuticals, Inc. - Financial Ratios
Financial Ratios - Capital Market Ratios
Financial Ratios - Annual Ratios
Financial Ratios - Interim Ratios
Financial Ratios - Ratio Charts

Section 4 - Appendix

Appendix
Methodology
Ratio Definitions
About GlobalData
Contact Us
Disclaimer


Note*: Some sections may be missing if data is unavailable for the company



List Of Tables


Oncogenex Pharmaceuticals, Inc., Key Information
Oncogenex Pharmaceuticals, Inc., Key Ratios
Oncogenex Pharmaceuticals, Inc., Share Data
Oncogenex Pharmaceuticals, Inc., Major Products and Services
Oncogenex Pharmaceuticals, Inc., History
Oncogenex Pharmaceuticals, Inc., Key Employees
Oncogenex Pharmaceuticals, Inc., Key Employee Biographies
Oncogenex Pharmaceuticals, Inc., Key Operational Heads
Oncogenex Pharmaceuticals, Inc., Other Locations
Oncogenex Pharmaceuticals, Inc., Subsidiaries
Oncogenex Pharmaceuticals, Inc., Key Manufacturing facilities
Oncogenex Pharmaceuticals, Inc., Key Competitors
Oncogenex Pharmaceuticals, Inc., SWOT Analysis
Oncogenex Pharmaceuticals, Inc., Ratios based on current share price
Oncogenex Pharmaceuticals, Inc., Annual Ratios
Oncogenex Pharmaceuticals, Inc., Interim Ratios
Currency Codes
Capital Market Ratios
Equity Ratios
Profitability Ratios
Cost Ratios
Liquidity Ratios
Leverage Ratios
Efficiency Ratios



List Of Figures

Oncogenex Pharmaceuticals, Inc., Performance Chart
Oncogenex Pharmaceuticals, Inc., Ratio Charts



Oncogenex Pharmaceuticals Inc (OncoGenex) formerly known as Sonus Pharmaceuticals Inc, is a drug discovery and development company that develops and commercializes therapies and mechaisms for addressing treatment resistance in cancer

View Report

Oncogenex Pharmaceuticals Inc (OncoGenex) formerly known as Sonus Pharmaceuticals Inc, is a drug discovery and development company that develops and commercializes therapies and mechaisms for addressing treatment resistance in cancer

View Report

Oncogenex Pharmaceuticals, Inc. (OGXI) - Financial and Strategic SWOT Analysis Review market research report at USD 300 and market update available at JSB Market Research.

View Report
There is no reviews available for this report

Select License Type

Delivery Details

Delivery Details : Electronic files (PDF) of market research reports will dispatched within 12 to 24 hours. (Mon-Fri IST)

Customized Report

If a particular report is not as per your requirement you can ‎choose "Customized Report". To visit click on -

Custom Research Reports